List of Publications-Journals
Journal of Publication
Aging Clinical & Experimental Research
Alzheimer Disease and Associated Disorders
Alzheimers Reports
Brain Research
Experimental Neurology
FASEB Journal
Journal of Alzheimer Disease
Journal of Comparative Neurology
Journal of Geriatric Psychiatry & Neurology
Journal of Neuroendocrinology
Journal of Neuropathology & Experimental Neurology
Neurobiology of Aging (3)
Neuroendocrinology
NeuroReport
Neuroscience Letters
Neuroscience (2)
Proc Natl Acad Sci USA (2)
Science
Trends in Neuroscience
Lucassen P.J., Tilders F.J.H., Salehi A., Swaab D.F. Neuropeptides vasopressin (AVP), oxytocin (OXT) and corticotropin releasing hormone (CRH) in the human hypothalamus: activity changes in aging, Alzheimer's disease and depression. Aging Clin. Exp. Res., 9: 48 50.
Click here To view the Abstract
Salehi A., Bakker J., Mulder M., Swaab D.F. Limited effects of neuritic plaques on neuronal density in CA1 hippocamal area of Alzheimer patients. Alz. Dis. Assoc. Dis. 1998 12, 77 82.
Click here To view the Abstract
Van Leeuwen F.W., deKleijn D.P.V., vandenHurk H.H., Neubauer A., Sonnemans M.A.F., Sluijs J.A., Koycu S, Ramdjiela R.D.J., Salehi A., Martens G.J.M., Grosveld F.G., Burbach J.P.H., Hol E.M. Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients: Transcript of live discussion, 28th May 1998 Alzheimers Reports 1998 1: 271-274.
Click here to view the Abstract
-
Top
Salehi A., Van de Nes J.A.P., Hofman M.A., Gonatas N.K., Swaab D.F. Early cytoskeletal changes as shown by Alz 50 are not accompanied by decreased neuronal activity.
Brain Res. 1995 678: 29 39.
Click here to view the Abstract
Salehi A, Ocampo M, Verhaagen J. and Swaab D.F. P75 Neurotrophin Receptor in the Nucleus
Basalis of Meynert in Relation to Age, Sex and Alzheimer's Disease. Exp. Neurol. 2000, 61: 245-58.
Click here to view the Abstract
Verwer R.W., Hermens W.T., Dijkhuizen P., Ter Brake O., Baker R.E., Salehi A., Sluiter A.A., Kok M.J., Muller L.J., Verhaagen J., Swaab D.F. Cells in human postmortem brain tissue slices remain alive for several weeks in culture. FASEB J 2002, (1):54-60.
Click here to view the Abstract
Yesavage JA, Friedman L, Kraemer H, Tinklenberg JR, Salehi A, Noda A, Taylor JL, O'Hara R, Murphy G. Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course.
J Geriatr Psychiatry Neurol. 2004,17(1):20-4.
Click here to view the Abstract
Lucassen P.J., Salehi A., Pool C.W., Gonatas N.K., Swaab D.F. Activation of vasopressin neurons in aging and Alzheimer's disease. J. Neuroendocrinol. 1994 6, 673 679.
Ishunina T.A., Salehi A., Hofman M.A. Swaab D.F. Activation of supraoptic nucleus in aging is sex dependent. J. Neuroendocrinology, 1999, 11: 251-258.
Click here to view the Abstract
Salehi A., Pool C.W., Mulder M., Gonatas N.K., Swaab D.F.
Activity of hippocampal CA1 neurons in Alzheimer's disease is not affected by the presence of adjacent neuritic plaques.
J Alz Dis, 1998, 1: 107-118.
Click here to view the Abstract
-
Top
Salehi A., Gonzalez Martinez V., Swaab D.F. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease.
Neurobiol. Aging, 1998, 19: 505-510.
Click here to view the Abstract
Van Leeuwen FW, Fischer DF, Kamel D, Sluijs JA, Sonnemans MA, Benne R, Swaab DF, Salehi A, Hol EM. Molecular misreading: a new type of transcript mutation expressed during aging.
Neurobiol Aging. 2000, 21: 879-91.
Click here to view the Abstract
Swaab D.F, Hofman M.A., Lucassen P.J., Salehi A., Uylings H.B.M. Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease.
Neurobiol. Aging 1994 15/3: 369 371.
Click here to view the Abstract
-
Top
Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC. Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome.
J Comp Neurol. 2004, 480(3):281-98.
Click here to view the Abstract
-
Top
Salehi A, Delcroix J.D., Swaab D. F. Alzheimer's Disease and NGF Signaling. J Neural Transm. 2004,111(3):323-45.
Click here to view the Abstract
Salehi A., Swaab D.F. Diminished neuronal metabolic activity in Alzheimer's disease. J. Neural Transmission, 1999, 106: 955-986.
Click here to view the Abstract
-
Top
Salehi A., Ravid R., Gonatas N.K., Swaab D.F.
The decreased activity of hippocampal neurons in Alzheimer's disease is not related to the presence of neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 1995 54, 704 709.
Click here to view the Abstract
Swaab DF, Salehi A. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol. 1997 56(2):216. J Neuropathol Exp Neurol. 1996 55(10):1023-5.
Click here to view the Abstract
-
Top
Ishunina T.A., Salehi A., Swaab D. F. Sex- and Age- Related P75 Neurotrophin receptor expression in the human supraoptic nucleus. Neuroendocrinology. 2000, 71: 243-51.
Click here to view the Abstract
-
Top
Salehi A., Verhaagen J., Dijkhuizen P.A., Swaab D.F. Colocalization of high affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 1996 75, 373 387.
Click here to view the Abstract
Salehi A., Lucassen P.J., Pool C.W., Ravid R., Ganatas N.K., Swaab D.F.
Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by size of the Golgi apparatus.
Neuroscience 1994 59: 871 880.
Click here to view the Abstract
-
Top
Salehi A., Heyn S., Gonatas N.K., Swaab D.F. Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus. Neurosci. Lett. 1995 193, 29 32.
Click here to view the Abstract
-
Top
Oleana V.H., Salehi A., Swaab D.F. Increased expression of the TIAR protein in the hippocampus of Alzheimer patients. NeuroReport 1998 9: 1451 1454.
Click here to view the Abstract
-
Top
Salehi A., Dubelaar E.J.G., Mulder M., Swaab D.F. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is ApoE type dependent.
Proc. Natl. Acad. Sci. USA, 1998, 95: 11445 11449.
Click here to view the Abstract
Cooper J.D., Salehi A., Delcroix J.-D., Howe C.L., Belichenko P.V., Chua-Couzens J., Kilbridge J.F., Carlson E.J., Epstein C.J., Mobley W.C. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A 2001, 98(18):10439-44.
Click here to view the Abstract
-
Top
Van Leeuwen F.W., de Kleijn P.V., van den Hurk H., Neubauer A., Sonnemans M.A.F., Sluijs J.A., Köycü S., Ramdijelal R.D.J., Salehi A., Martens G.J.M., Grosveld F.G., Burbach P.H., Hol E.M.
Framshift mutations of amyloid precursor protein and ubiquitin B in Alzheimer's and Down Patients. Science 1998, 279: 242 247.
Click here to view the Abstract
-
Top
Salehi A, Delcroix JD and Mobley WC. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends Neurosci. 2003, 26 73-80.
Click here to view the Abstract
-
Top
ABSTRACTS
Salehi A., Van de Nes J. A. P., Lucassen P. J., Hofman M. A., Gonatas N. K., Swaab D. F. Relation between neural activity and cytoskeletal alterations in Alzheimer disease. International Workshop on the Borderland Between Normal and Pathological Mental Aging. Amsterdam, The Netherlands. June 5 8 1994, p 10.
Swaab D.F., Hofman M. A., Raadsheer F. C, Salehi A., Van de Nes J. A. P., Proceeding Physiological vs. pathological aging in the human hypothalamus. 6th congress of the International Psychogeriatric Association Berlin, Germany. Sep. 5 10 1993.
Swaab D.F., Raadsheer F. C, Van de Nes J. A. P., Salehi A., Ravid R. Lack of relationship between Alz 50 staining, B A4 accumulation and neural activity in the human hypothalamus of Alzheimer's patients. Neurobiol. Aging 15, Suppl. 1, abstr. 571
Salehi A,. Verhaagen J., Kaplan D., Swaab D.F. Expression of high affinity neurotrophin receptors (trkA, B and C) in the nucleus basalis of Meynert of the human brain. 1995. J. Cell. Biochem. S21B.
Salehi A., Verhaagen J, Swaab D.F. Differential reduction in high affinity neurotrophin receptors in the nucleus basalis of Meynert of Alzheimer's patients. Eur. J. Neurosci. Suppl 8. p173
Swaab D.F., Van Someren E.J.W., Lucassen P. J. Salehi A. Alzheimer changes in hypothalamic nuclei: their relationship to neuronal activity and clinical symptoms. Proceeding to Connexions, Cognition et Maladie D' Alzheimer. May 1996. Paris, France.
Kamel A., Salehi A., Sonnemans M.A.F., Swaab D.F., van Leeuwen F.W. Comparison of early markers for Alzheimer's type neurodegeneration within the hypothalamus. The 6th International Conference on Alzheimer's Disease and Related Disorders. Neurobiol. Aging, July August 1140, 1998.
Salehi A., Cooper J., Delcroix J.-D. and Mobley W.C. (2000) Degeneration of the Basal Forebrain in a Mouse Model of Down Syndrome, Evidence of a Role for Defective Trophic Support. World Alzheimer Congress 2000, Washington DC.
Belichenko P.V., Salehi A., Delcroix, J.-D., Cooper J. and Mobley W.C. (2000) Neuronal and synaptic alterations in the partial trisomy 16 mice. "Neurodegenerative Disorders: Common Molecular Mechanisms" Tobago, West Indies.
Belichenko P.V., Salehi A., Delcroix J.-D., Cooper J., Mobley WC (2000) Neuronal and synaptic alteration in the partial trisomy 16 mice. Society for Neuroscience's 30th Annual Meeting, November 4 - 9, 2000. New Orleans, LA.
Verwer R.W.H., Hermens W.T.J.M.C., Dijkhuizen P.A., ter Brake O., Baker R.E., Salehi A., Sluiter A.A., Kok M.J.M., Verhaagen J., Swaab D.F. (2000) Cultured postmortem human brain tissue slices respond to experimental manipulations and show long-term expression of transgenes. Society for Neuroscience's 30th Annual Meeting, November 4 - 9, 2000. New Orleans, LA.
Salehi A., Cooper J.D., Epstein C.J., Mobley W.C. Age-related cholinergic and serotoninergic abnormalities in a mouse model of Down syndrome. Society for Neuroscience's 31st Annual Meeting, San Diego, CA November 10 - 15, 2001.
Salehi A., Huang L., Villar A., Epstein C.J., Mobley W.C. Segmental trisomy for the region of mouse chromosome 16 from Gabpa to Sod1 is responsible for the age dependent atrophy of basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome. The 8th International Conference on Alzheimer's Disease and Related Disorders, Stockholm, 20-25 2002
Salehi A. J.-D. Delcroix, L. Huang, A. Villar, C.J. Epstein, W.C. Mobley. Genetic dissection of failed NGF retrograde transport and degeneration of basal forebrain cholinergic neurons in a mouse model of Down syndrome. Society for Neuroscience, Orlando, FL, November 2002
Salehi A., Delcroix J.D., Selwood S., Zhang S., Xia W., Sambamurti K., Villar V., Epstein C.J., Mobley W. Gene expression studies in a mouse model of Down syndrome. Society for Neuroscience, New Orleans, LA, November 2003.
Honda M., Salehi A., Hesla P., Maehlen J., Einen M.A., Mishima K., Nishino N., Mignot E. Gene expressioin in narcoleptic postmortem hypothalamus using microarray. Society for Neuroscience, New Orleans, LA, November 2003.
Delcroix J.M., Salehi A., Valletta J.S., Epstein C.C., Villar V., Belichenko P.V., Stokin G., Lamb B., Goldstein L.S., Mobley W.C. Overexpression of the gene for amyloid precursor protein (App) disrupts retrograde transport of NGF. Society for Neuroscience, San Diego, October 2004.
Salehi A. Takimoto R., Epstein C.J., Mobley W.C. Gene expression in dentate granule cells of mouse models of Down syndrome. Society for Neuroscience, San Diego, October 2004.
Honda M, Salehi A, Honda Y, Hesla P, Maehlen J, Tanaka S. , Einen M, Gaus S, Mignot E.
Experssion of galanin and dynorphin decreases in parallel with hypocretin in human narcoleptic hypothalami, suggesting acquired hypocretin neuron loss as the cause of hypocretin deficiency/narcolepsy syndrome. Society for Neuroscience, San Diego, October 2004.